Financials

  • Market Capitalization 12.13 M
  • Employee 18
  • Founded 2016
  • CEO N/A
  • Website www.in8bio.com
  • Headquarter Delaware, United States
  • FIGI BBG00XX9K1M2
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.53
Rapporto prezzo/fatturato
—

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4587
CTXR
Citius Pharmaceuticals, Inc. - Common Stock
0.49 USD-2.00%-5.77%-15.52%-61.11%13.45 M USD
4611
AEON
AEON Biopharma, Inc. Class A Common Stock
0.25 USD-10.71%-7.41%-24.24%-75.96%12.47 M USD
4622
GTBP
GT Biopharma, Inc. - Common Stock
6.72 USD+0.60%+6.16%-22.31%+873.91%12.13 M USD
4625
PLUR
Pluri Inc. - Common Stock
0.97 USD+14.12%-7.62%-18.49%-74.62%11.97 M USD

Notizie